NEW YORK (GenomeWeb) – Meridian Bioscience said today that its fiscal third quarter revenues increased 2 percent year over year on strong sales in its Diagnostics unit.

For the third quarter ended June 30, Cincinnati, Ohio-based Meridian posted net revenues of $48.2 million compared to $47.2 million in the year ago quarter and falling shy of analysts' consensus estimate of $48.6 million. Excluding a negative foreign currency effect of approximately $1.5 million, revenues grew 5 percent, Meridian said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.